Hemostatic abnormalities in patients with severe preeclampsia

被引:56
作者
Heilmann, Lothar
Rath, Werner
Pollow, Kunhard
机构
[1] Perinatal Ctr, Dept Obstet & Gynecol, D-65428 Russelsheim, Germany
[2] Univ Aachen, Dept Obstet & Gynecol, D-5100 Aachen, Germany
[3] Johannes Gutenberg Univ Mainz, D-6500 Mainz, Germany
关键词
pregnancy; severe preeclampsia; thrombin generation; thrombomodulin;
D O I
10.1177/1076029607299986
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Preeclampsia is the most common medical disorder of pregnancy. Early onset preeclampsia is defined as presentation of hypertension and proteinuria before 34 weeks of gestation. Alterations of endothelial cells and fibrin deposition in microvasculature lead to enhanced activation of the coagulation cascade and impaired fibrinolysis associated with multiple organ dysfunctions. Plasma samples were obtained from 50 patients with severe preeclampsia before 34 weeks of gestation and in 61 patients with late preeclampsia. Factor VIIIR:Ag, fibrinogen, D-dimer, and thrombomodulin increased with advanced pregnancy. The platelet count is very important because of the close correlation with the activations parameters of D-dimer and antithrombin. Our results were consistent with activated coagulation and lowering of platelet count in severe cases with early onset preeclampsia. Women who develop early onset preeclampsia characterized a subgroup of patients with more and severe hematologic abnormalities than women with late preeclampsia (after 34 weeks of gestation).
引用
收藏
页码:285 / 291
页数:7
相关论文
共 47 条
[1]   Reducing unnecessary coagulation testing in hypertensive disorders of pregnancy [J].
Barron, WM ;
Heckerling, P ;
Hibbard, JU ;
Fisher, S .
OBSTETRICS AND GYNECOLOGY, 1999, 94 (03) :364-370
[2]   Coagulation and fibrinolysis parameters in normal and in hypertensive pregnancies [J].
Bellart, J ;
Gilabert, R ;
Fontcuberta, J ;
Borrell, M ;
Miralles, RM ;
Cabero, L .
HYPERTENSION IN PREGNANCY, 1998, 17 (02) :115-123
[3]  
Boffa MC, 1998, THROMB HAEMOSTASIS, V79, P1092
[4]  
Boffa MC, 1996, HAEMOSTASIS, V26, P233
[5]  
BREMME K, 1992, OBSTET GYNECOL, V80, P132
[6]   Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction [J].
Bretelle, F ;
Sabatier, F ;
Desprez, D ;
Camoin, L ;
Grunebaum, L ;
Combes, V ;
D'Ercole, C ;
Dignat-George, F .
THROMBOSIS AND HAEMOSTASIS, 2003, 89 (03) :486-492
[7]   Hypertension in pregnancy: Maternal and fetal outcomes according to laboratory and clinical features [J].
Brown, MA ;
Buddle, ML .
MEDICAL JOURNAL OF AUSTRALIA, 1996, 165 (07) :360-365
[8]   Acquired activated protein-C resistance in pregnancy and association with increased thrombin generation and fetal weight [J].
Clark, P ;
Walker, ID ;
Greer, I .
LANCET, 1999, 353 (9149) :292-293
[9]  
Clark P, 1998, THROMB HAEMOSTASIS, V79, P1166
[10]  
Clark P, 2001, THROMB HAEMOSTASIS, V85, P30